OCA
GRCL

Octagon Capital Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Octagon Capital Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-596,611
Closed -$5.99M – 65
2023
Q4 		$5.99M Buy
+596,611
New +$5.99M 0.96% 22